Since its creation, Solthis has adopted the principle of non-substitution as a founding element of its intervention strategy. Our organisation intervenes in support of existing public structures and local stakeholders, building their skills and functioning so that health services can be accessible, of good quality, efficient and fair for all populations.
Solthis’ strategy is rooted in the following definition: “capacity building is a long-term process which improves the ability of an individual, a group, an organisation or an ecosystem to generate positive change and perform better to improve public health results” (Management Sciences for Health, Challenges encountered in capacity building, April 2010).
Solthis distinguishes between three levels of capacity building: individual, structural and national.
Solthis includes 4 types of support in its strengthening strategy: the skills of health professionals, material assets in their workplaces, as well as the organisation of services and the coordination of stakeholders.
“Solthis helps to strengthen health systems by accompanying the empowerment of medical care professionals. It is about enabling them to have all the necessary elements such as training and equipment when implementing their actions.” Etienne GUILLARD, Director of Health Systems and Services Strengthening.
Our strategy of capacity building among local stakeholders of health services and systems
To accompany and shape human resource in health:
pharmacists and members of the pharmaceutical system
professionals in charge of health information system
staff from regional and national Ministry of Health senior management
Improving the organisation of healthcare circuits, input supply and swab testing as well as the coordination between different health services and players in health policy.
An established methodology of capacity building and change accompaniment
Solthis’ methodology, which is defined in its Capacity Building Manual, proposes an intervention consisting of 4 stages:
Analyse and plan actions around developing skills by carrying out an assessment and determining objectives to improve quality
Examine existing capacities: there are pre-existing skills in all cases of intervention and it is more effective to build upon those that already exist. We use a participative approach to identify needs, thus promoting ownership by stakeholders.
Collectively construct a proposition of intervention: this involves planning and setting objectives to be met by favouring methods allowing care teams to take ownership.
Put in place collectively the selected actions of capacity building, improving organisation and the material working conditions
Monitor results: follow changes being put in place, and analyse the evolution of care data and quality indicators
Evaluate the impact of the changes on improving quality of care to decide whether to adopt, adapt or abandon the actions tested
In order to improve change management results, Solthis has adopted a structured support approach for treatment sites. This is inspired by the Quality Improvement Initiative (QII) of developed countries in the area of hospital management which has been adapted to the context of developing countries.
Our actions on the ground
Health policy support
Support, advice and expertise from decision-makers (Ministry of Health, regional directors and technical groups)
Influencing/Improving national norms and procedures, input supply and biological
Change management in health structures
Organisational advice for improving patient circuits, input supply, biological samples; helping the distribution of tasks and improving communication within teams.
Material conditions: helping to purchase equipment
Infrastructure: restoration and planning
The substantive work undertaken by Solthis on the improvement of their educational methods has revealed the importance of post-training follow-up and continuous support between training in order to obtain a real change of practices among care staff.
Our approach consists of identifying training needs, defining these needs, then proposing an individual training plan adapted to the needs of each individual with:
Training for trainers of national partners
Classroom training on medical care: initial training and refresher classes.
Regular locally-based clinical guidance training among nursing teams
Training leading to a qualification, Internet and organising south-south work placements in library reference services
Interactive training modules adapted to countries’ realities:
Screening and advise on nursing staff’s initiative
Prevention of mother-to-child transmission
Medical care of adults living with HIV
Medical care of children exposed to and infected by HIV
Psychological care of adults living with HIV
Pedagogical films on interpersonal skills and expertise to allow staff undergoing training on providing advice and support services to improve their attitude, effective communication and the quality of the information that they relay.
Card games on HIV therapy
Technical datasheets & decision support tools
Technical datasheets of products and machines
Diagnostic support tools for opportunistic infections
Biological, immunological and virological monitoring support tools
Measurement of viral load: transportation of samples, manual extraction guide
Updating quantification tools and supply of stock, accompanied by utilisation manuals
This French – English translation was done by the translator Lauren Hornsey and proofread by Neil Hewat for the PerMondo project that involves providing free translations for NGOs. This initiative is sponsored and run by the translation agency Mondo Agit.
27th of June 2014, Solthis will held its annual Scientific Day in the presence of its field teams.
Such as every year Solthis also invites its technical and financial, medical, institutional, associative partners.
Discussions will focus on three major themes :
- HIV and infectious diseases (hepatitis, tuberculosis and neurological opportunistic infections)
- Mother and Child Program, a public health priority in sub-Saharan Africa
- Key Populations: crossed viewpoints
On the occasion of the 17th International Conference on AIDS and STIs in Africa (ICASA), Solthis organized the December 10th, with the participation of EGPAF, ICAP and MSH, a satellite on quality improvement. Oriented on field experiences, exchanges have helped to highlight the current challenges and the main advances.
On 28th june at the Pitié-Salpêtrière, Sothis organized its Scientific Day in the presence of its field teams. Medical, institutional, associative, technical and financial partners were present too. Discussions focused on 5 topical issues : paediatrics, hepatitis C, virological monitoring, Global Fund and monitoring-evaluation.
University of Washington, department of Global Health – march 2012
Création d’un hôpital de jour à l’Hôpital National de Niamey : Le vécu des patients sur l’évolution du continuum de soins
Autor(s) : S. Mohamadou, M. Idé, G. Lurton, E. Adehossi, B. Madougou, H. Toure, E. Guillard, F. Huber, C. Dézé, S. Diallo
Download the posterMettre en œuvre un programme public d’éducation thérapeutique des patients vivants avec le VIH dans les centres prescripteurs d’un pays à ressources limitées : l’expérience du Niger
Autor(s) : Fati Maiga, Agnès Certain, Hadiza Baoua, Mamane Harouna, Caroline Gallais, Oumarou Seybou, Souleymanou Mohamadou, Pierre Teisseire, Sanata Diallo, Florence Huber, Sophie Calmettes, Etienne Gillard
Download the posterPrévalence du risque cardiovasculaire évalué d’après les mesures des plis cutanés - Étude transversale au Niger
Autor(s) : V. Moyà Alvarez I. Baragé, Y. Hanki, I. Dillé, F. Huber, G. Lurton, Y. Madec
Download the posterLa difficulté du suivi des enfants infectés par le VIH au CHU Gabriel Touré de Bamako (Mali)
Autor(s) : M. Sylla, H. Coulibaly, F. Dicko-Traoré, A. Akondé, G. Lurton, A. Diakité, A. Diallo, C. N'Diaye, M. Traoré, S. Touré, N. Koné, T. Sidibé
Download the posterUne prévalence préoccupante de résistances transmises aux antirétroviraux chez les hommes ayant des relations sexuelles avec des hommes à Madagascar
Autor(s) : S. Andriantsimietry, F. Lamontagne, M. Randria, M.L. Chaix, L. Pizarro, R.L. Razanakolona, C. Rouzioux
Download the posterEnjeu de la prévision des besoins avec des données faibles : expérience d'utilisation de projections par scénarios en Guinée
Autor(s) : G. Lurton, M. Diallo, E. Guillard
Download the posterComparaison de l'apport des examens microbiologiques au diagnostic de la tuberculose chez les PVVIH au Niger. Données préliminaires d'une étude interventionnelle
Autor(s) : M. Idé, S. Mohamadou, A. Yacouba, O. Seybou, R. Abba, S. Mamadou, F. Lamontagne, I. Diallo, G. Lurton, F. Huber, S. Diallo
Download the posterLe défi de la coordination des approvisionnements : l'exemple réussi du "Groupe Approvisionnement" au Niger
Autor(s) : Z. Ankourao, I. Mato, A. Messan Ganfled, S. Ouvrard, E. Guillard
Download the poster
Consolider l’apprentissage des connaissances thérapeutiques sur le bon usage des traitements ARV par les professionnels de santé à partir d’un jeu de carte innovant : « La thérapeutique VIH en jeu»Author(s) : Charlotte Dézé, E. Guillard, S. Ouvrard, M. Diallo, P. Autret
Dealing with uncertainty the challenge of long term projections in low data resources countries
Author(s) : M. Diallo, G. Lurton, E. Guillard
Connaître son virus, connaître son épidémie : contribution de la virologie moléculaire à la compréhension de l’épidémie VIH
Author(s) : Franck Lamontagne
Presentation non available
Identification d'un cluster viral à l'origine d'un taux élevé de résistance primaire aux ARV au niveau national : le cas singulier de Madagascar
Author(s) : F. Lamontagne, S. Andriantsimietry, M.L. Chaix, M. Randria, J. Nely, C.B. Ramamonjisoa, J.S. Lalao, H. Rahasana, G. Lurton, L. Pizarro, F. Huber, R.L. Razanakolona, C. Rouzioux
Download the posterBilan de 10 ans de prise en charge pédiatrique au CHU Gabriel Touré de Bamako (Mali)
Author(s) : M. Sylla, H. Coulibaly, F. Dicko-Traoré, A. Akondé, G. Lurton, A.A. Diakité, A. Diallo, C.N'Diaye, M. Traoré, S. Touré, N. Koné, T. Sidibé
Download the posterHétérogénéité des pratiques et difficultés diagnostiques de la tuberculose chez les personnes infectées par le VIH à Niamey, Niger
Author(s) : R. Abba, F. Lamontagne, M. Souleymanou, O. Seybou, Y. Hanki, S. Diallo, G. Lurton, S. Mamadou
Download the posterManifestations neurologiques chez les patients hospitalisés au CHU de Conakry : un diagnostic à améliorer compte tenu de leur impact majeur sur la mortalité
Author(s) : G. Choaken, R. Vilain, F. Lamontagne, G. Lurton, M. Barry, A.A.S. Diallo, L. Laho, D. Mandiou, E. Papot, F. Huber, M. Cissé
Download the posterOffrir systématiquement le dépistage VIH en milieu de soin : une urgence de santé publique
Author(s) : R. Vilain, G. Choaken, F. Lamontagne, G. Lurton, M. Barry, A.A.S Diallo, L. Laho, D. Mandiou, E. Papo, M. Cissé, F. Huber
Download the posterAméliorer la prévention de la transmission du VIH de la mère à l'enfant en Guinée selon une démarche participative d'accompagnement au changement
Author(s) : C. Dézé, H. Yous, A. Keita, T.C. Sidibé, S. Calmettes, N. Barsacq, F. Lamontagne
Download the poster
Prof. C. Katlama, Prof. G. Brücker et S. Calmettes
On the occasion of its General Assembly, Solthis held Wednesday, July 6 at the Pitié-Salpêtrière, the 4th day meeting. Teams Solthis and partners in the field were present, especially from Mali, Guinea, Niger and Haiti.
The presentations are available below on this page.
HIV testing: a challenge?
Y. Yazdanpanah, F. Huber, R. Tubiana, M. Idé
At the "Test and Treat", screening is an important theme in African contexts, as in Western countries. Also, the first workshop of the Scientific Day Solthis it was dedicated, moderated by Dr. M. Ide (Niger) and Dr. R. Tubiana (Paris).
In his introduction, Dr. F. Huber (Solthis) presented the technical aspects of "rapid tests" raising the question of the limits of these tests, and the problem of lack of due process and the frequent inability to meet the temperature conditions recommended by the suppliers. This presentation was followed by a review of different screening strategies and the historical evolution of paradigms: the screening called "voluntary" to "provider-initiated testing for carers" as advocated by WHO and the various authorities health. Aspects of "cost effectiveness" of screening were then analyzed by Prof. Y. Yazdanpanah (Tourcoing). Dr. F. Lamontagne (Solthis Guinea) and Prof. M. Cisse (Guinea) have supported these statements by the West African experiences Solthis on screening in the care environment "opt out". If this type of screening "at the initiative of the caregiver" has made great advances in PMTCT or in tuberculosis centers, much remains to be done in other departments of medicine, where a high proportion of patients is not detected, not supported. Mobilization on this issue is more strategic than ever.
Despite the investment of Solthis on supply issues (ARV, all health products ...), stock-outs, especially for ARVs, are still common in the field and directly threaten the health of patients. The session dedicated to these issues was conducted by two doctors Dr. B. Diallo (Mali) and Dr. PM Girard (Paris).
E. Guillard (Solthis Pharmacy Manager) said the overall functioning of the supply before presenting the main causes that lead to situations of stockouts. The threat of disruption of Guinea in February 2011 was taken as an example to highlight the failures at different levels of decision making. Teams in the field of pharmacy Solthis and their partners then described their daily actions, emphasizing the mode of intervention or Solthis tools developed together, such as coordinating groups and committees for monitoring supplies, tables edge compilation, analysis, alerting, quantification tools ... Finally, J. Langlois (Sidaction) and F. Foguito (TAW), representing civil society, concluded the session by the role of associations to fight against breakage, and more widely to improve the quality of care.
Prof. V. Calvez (Pitié-Salpêtrière, Paris) presented the situation of primary resistance throughout the world, before recalling the consequences attributable to virological choice of first-line treatments. He raised the problem of low genetic barrier of molecules commonly used in countries with limited resources (especially NNRTIs), especially when access to viral load is small or nonexistent.
This session, moderated by Prof. M. Cisse (Guinea) and Dr. G. Breton (Paris), addressed the issue of retention of patient care in the circuit, through various initiatives. After a general introduction of G. Lurton (Solthis), Dr. M. Ide (National Hospital of Niamey) lamented the difficulties of long-term monitoring of HIV patients in Niger, based on the experiences of ambulatory treatment center and day hospital in Niamey. The experience of Medecins du Monde, supporting marginalized populations in integrated centers in Asia, was reported by Dr. N. Luhman. Finally, Dr. Claude Pean, Haitian Institute Pereo Fame, introduced the operation of the center of Port-au-Prince, who has built an international program based on improving the encrypted performance.
The Scientific Days of Mali experts have gathered several members of the Working Group Solthis: Christine Katlama, Roland Tubiana and Gilles Brucker. Solthis co-organized the National Day which brought together over 300 Malian professionals involved in the fight against HIV. For Solthis and its partners, it was an opportunity to present the results of the management and discuss immunological and therapeutic advances.
HIV prevalence and renutrition in children hospitalised for severe malnutrition in Niamey (Niger)Autor(s) : R. Maiga-Mamadou, W. Alkassoum, M. Hamadou, A. Abdou, C. Pizzocolo, S. Diallo, C. Dezé, V. Moya-Alvarez, F. Huber, Y. Madec
Evolution de la prise en charge du VIH à Ségou entre 2003 et 2009
Author(s) : L. Diakité, D. Katilé, , N. Diallo, A. Doumbia, MS. Koné, B. Coulibaly, A. Sidibé, Y. Coulibaly, A. Akondé, G. Lurton, F. Huber
Download the presentationEvaluation de la mise en place du dépistage et de la prise en charge du VIH au centre antituberculeux Carrière, à Conakry (Guinée)
Author(s) : LM. Camara, B. Bah, D. Touré, P. Kourouma, L. Hajouji, C. Katlama, F. Huber, O. Sow
Download the presentationDélégation de la prescription des antirétroviraux aux paramédicaux dans la PTME à Ségou (Mali)
Author(s) :A. Doumbia, A. Sidibé, AT. Traoré, A. Akondé, F.Z.T. Sangaré, DC. Traoré, M. Maiga, AM. Soumaré, F.D. Cissé, SD. Naman, G. Lurton, C. Katlama, F. Huber
Download the presentationCharge virale en routine dans un pays à ressources limitées : le cas du Niger
Author(s) : Dr Hanki, H. Yahayé, S. Mamadou, I. Aboubacar, R. Ali Maazou, I. Dillé, C. Dézé, S. Diallo, F. Huber, M. Amadou, F. Maïga
Download the presentationL'épidémiologie des perdus de vue dans les programmes VIH/SIDA
Author(s) : E. Poulet, M. Pujades-Rodriguez
Download the presentationL'approche anthropologique des ruptures de suivi médical des personnes vivant avec le VIH : l'exemple de Kayes (Mali)
Author(s) : S. Carillon, V. Petit
Download the presentationLes patients sous ARV perdus de vue : l'expérience de l'ONG WALE
Author(s) : D. KatiléDownload the presentation
Corrélation entre les activités d'éducation thérapeutiques (ETP) et l'échappement virologique au Niger : Les activités d'ETP sont-elles favorables au succès virologique ?
Autor(s) : H.Baoua, M. Naba Fati, I.Amy, F.Maïga, M.Saidou, G.Lurton, S.Diallo, E.Guillard, F.Huber., L.Pizarro
Download the posterCréation d'un outil permettant de visualiser simplement la couverture des besoins en ARV dans un contexte d'extension de la prise en charge
Autor(s) : E. Guillard, X. Paris, S. Ouvrard, M. Diallo, L. Pizarro
Download the posterPremière évaluation nationale de la réponse virologique aux antirétroviraux à Madagascar
Autor(s) : S. Andriantsimietry, F. Lamontagne, M. Randria, J. Nely, S. Randriamampionona, VJ. Soanomena, WR Lehimena, JN Andriambelo, F. Huber, L.R. Razanakolana
Download the poster"Effet-centre" et fidélisation du patient infecté par le VIH dans le circuit de soin. Expérience de 2 pays Ouest-africains
Autor(s) : F. Huber, A. Akondé, G. Lurton, I. Kamaye, AB. Dicko, S. Diallo, S. Tchiombiano, N. Daries, P. Teisseire, L. Pizarro
Download the poster
This number is published on the occasion of the Francophone Conference, Solthis revisits some of which abstracts will be presented.Interviews with Himmich Pr, Pr Pr Delaporte & Brucker, the co-chairs of the Conference
Screening: The déspistage initiated by the Caregiver and the rapid screening tests
Biological monitoring: Reactions of experts to study the DART
Folder on the phenomenon of Lost to: What tools? what response?
Tuberculosis: The MDR / XDR and Practical Guide to WHO in its fight against infections
Folder on the new WHO recommendationsPharmacy management tools
The Scientific Days, organized by the ULSS and CMT, in partnership with Solthis and GIP Esther, took place on 2 and 3 October 2009 in Niamey in the presence of Professor Katlama (Solthis President), Prof. Brucker (Treasurer Solthis and CEO of Esther) but also of Dr Kassi (Ivory Coast) and Professor Toure (Senegal).
More than 250 physicians, health professionals, representatives of the fight against HIV, tuberculosis in Niger attended these days. Many topics on Chess therapeutic Opportunistic Infections, PMTCT, Accidents of exposure to blood and the delegation of tasks were discussed.
Over a hundred people came to attend the Scientific Solthis Day on June 26. Players on the field of SOLTHIS, France or Paris, they met for the highlight of the association. Also, many distinguished guests were present: representatives of national and international institutions, the Global Fund, civil society actors ... Today, all teams SOLTHIS wishes to thank those who were able to attend this day to the quality of exchanges, the wealth of information and their demonstrated interest in our actions.
Scientific Day of Solthis is also an opportunity to give voice to field to present the projects implemented and to share their thoughts on the challenges of HIV disease. See you in 2010!
Proceedings of the Round TableWhat future for international funding of HIV programs?
In the current economic crisis and crisis funding, SOLTHIS wanted to set up a reflection on this vast subject. The roundtable, chaired by Professor Gilles Brucker, gave rise to two questions, firstly that of continuous funding for the fight against HIV and the effectiveness of such funding. This debate was thus the occasion for Prof. Patrice Debré, new Ambassador in charge of the fight against HIV AIDS, to outline the challenges and the strategy it intends to introduce. Dr. Florence Veber, Assistant Director for Health and Human Development (MFA) has expressed his current thinking on innovative financing and recalled in place of the fight against HIV in health policy. Representatives of civil society were also at the table. Marie-Alexia Delerue, of Action for Global Health, called for a mobilization of governments for development of new sources of funding in addition to their official development assistance. As for Khalil Elouardighi, Coalition of More, he warned of the serious short-term decline in funding from the Global Fund, particularly for patients néceisstant treatment of second and third line.
Prof. Patrice Debré: Patients and international partnerships
Prof. Patrice Debré is the new Ambassador in charge of the fight against HIV / AIDS and infectious diseases.There is also a co-founder of Solthis.
Professor Debre presented the characteristics of the epidemic: 33 million people infected with HIV, 2.7 million new infections per year, two million deaths 75% in Saharan Africa. A disease that affects both women that man ... In countries é low or middle income, the access to ARVs is limited: only 31% of global demand for ARVs are covered. .. HIV was the illness that led to the concept of "Global Health" to emerge, this awareness of global health has led to considerable social and political commitments for which new resources and new funds were needed .
Then, the Ambassador outlined the contribution e franéaise the fight against pandemics based financing channels in 2007:
- For HIV: 363 million euros, 20 million for bilateral (AFD, Esther, ... AT MFA) and 26 million for Research (ANRS, IRD, CNRS ...).
- For malaria: 100 million for multilateral and bilateral for zero.
- For TB: 31 million for multilateral and bilateral 3 million for.
Finally, Professor Debré expressed challenges in the fight against HIV at international level:
1. Harmonization of the Governance of International Health
2. Cooperation among the multilateral organizations
3. Complementarity between the bilateral and the multilateral
4. European dimension
5. Support in general
6. Integrated approach between basic and clinical research, opening e other areas such as agronomy
7. Multiplication of innovative financing
Dr. Florence Veber is currently in charge of the Sub-Directorate of Health and Human Development of the Ministry of Foreign Affairs and European.
Dr. Florence Veber presented the new organizational structure of Ministry of Foreign Affairs and European set up to be in phase with the emergence of global issues like climate change or pandemics. She outlined the three main directions:
1. Administrative direction
2. Diplomatic lead (geographical division)
3. Overall direction of globalization development, partnerships and development.
This new direction is divided into four sub-directorates including the Directorate of global public goods including climate, natural resources (forests and water), food security and health and human development. Led by Dr. Veber, this sub-directorate deals with issues of health but also education, employability, gender equality, migration, demography and social protection.
To date, this sub-department is particularly sought for the monitoring of commitments in the multilateral franéais since 75% of the budget of the health cooperation through multilateral channels. She is in charge of policy definitions, the Operational being managed by AFD (Franéaise Development Agency). Moreover, the strategy of cooperation policy for health should be reviewed to the end of 2009 with the participation of stakeholders. This new team wants to offer stakeholders greater access and transparency to the data field to promote shared approaches among other NGOs and the Ministry.
Dr. Veber has shared his thoughts of two topics:
1. Consequences of funding for HIV / AIDS on strengthening health systems?
2. Efficiency and use of innovative financing in health?
Marie-Alexia Delerue: Health Care Financing
Marie-Alexia Delerue is responsible for advocacy at Medecins du Monde, a member of the NGO network European Action for Global Health.
Marie-Alexia Delerue presented the evolution of financing Development assistance for health:
- International: 4-fold increase between 1990 and 2007;
- At European level: 58% increase from 2001 e 2007;
- In France: 4-fold increase between 2000 and 2007;
- Sources: Public sources of funds, but increasingly the private / philanthropic (26.7% of total international aid health in 2007);
- Channels: increased multilateral channel (GFATM, GAVI).
If this international movement, ed through increased international funding, has achieved considerable progress in terms of health (reduction of child mortality, increasing the number of patients having access to ARVs ...), we find that health issues in the South are immense: the eight Millennium Development Goals (MDGs), who increased the least are those for e health. Funding and predictability are still insufficient.
In the current economic crisis, health indicators are threatened. The WB report on the global crisis provides that if any international response is urgently adopted to support developing countries, approximately 200 000 e 400 000 children under 5 years and more will lose their lives each year. It is therefore fondammental that donors meet their financial commitments in favor of health.
Today, NGOs are calling on international donors and governments in the South:
- Putting health at the heart of development policies (for developing countries, have 15% of their health budget e)
- Respect the commitments made by donors in the framework of the G8
- Promote the strengthening of health systems
- Develop new funding sources, including quickly implement the tax on currency transactions, which could bring in $ 40 billion by annnée and would therefore make a real difference in terms of scale of development finance and accelerate the progress of health indicators. Innovative financing must be additional e the official development assistance and truly predictable.
The 15th International Conference on AIDS and Sexually Transmitted Infections in Africa was held from 3 to 7 December 2008 in Dakar. It was an important time to take stock of the various initiatives in the fight against HIV / AIDS implemented in Africa.
For Solthis, this conference was an opportunity to present at international level, the work done for 5 years, its action on the ground every day, in direct support of care teams and national health policies. Several papers were presented by members of Solthis, a satellite-symposium was organized, open to the public of broadcasts in partnership with RFI have been put in place ... Every day, the teams were present at booth to greet visitors and answer their questions.
An oral presentation
View lost in Segou (Mali) What drives HIV patients who receive free care to give it up and leave the circuit centers of care?
To try to answer this question, Gregory Lurton, project manager of information systems, presented the investigation into the missing=in Segou and the work on information system support.
View lost in Segou, Gregory Lurton
Solthis' teams participated to the drafting of several posters presented at the congress.
Solthis, in partnership with the Respasi (African Network of Practitioners Providing the Medical Management of People Living with HIV AIDS), held a symposium on satellite support transfronalière of phas in Africa. Indeed, more and more patients living with HIV / AIDS are required to travel within Africa. These movements can compromise the quality of their support for issues related to harmonization of the provision of care, equity of access to care, monitoring and tracking of patients and the vulnerability of these patients.
Solthis and the issuance of Priority Health Hédon Claire, broadcast daily on RFI, have partnered to offer the public a forum of ICASA. A recording booth in the center of the village association was installed to host two shows.
Priority health - Thursday, december 4
The first issuance took hold of the XV ICASA for an update on the current state of research on treatments against HIV: what the state of research in the North and the South?
Professor Jean-Francois Delfraissy, Director of the ANRS, Professor Papa Salif Sow, Co-Chair of the Scientific Program Committee of the XV ICASA and Dr Diallo Sanata, medical coordinator in Niger Solthis met to take stock of research and its implementation in countries in Africa. They answer questions from the public and Claire Hédon of ICASA.
Priority health - Friday, december 5
What about access to treatment in Africa, what is the state of care for patients living with HIV / AIDS?
In a second issue carried out as part of the XV ICASA, Claire Hédon pose his questions to Professor Christine Katlama of Pitie Salpetriere Hospital in Paris, and President of Solthis, Dr. Alain Akondé, Medical Coordinator for Solthis Mali and Pr Serge Eholié CHU Treichville in Abidjan.
Les perdus de vue de la région de Ségou, au Mali
Author(s) : G. LurtonDownload the presentationPrise en charge transfrontalière des PVAVS : le point de vue du soignant
Author(s) : S. DialloDownload the presentationMigrations transfrontalières en Afrique de l'Ouest : le regard des sciences sociales
Author(s) : S. TchiombianoDownload the presentationContinuum des soins et politique d'accès aux traitements des IST/VIH/SIDA dans les cinq pays du Corridor Abidjan-Lagos
Author(s) : J. KoffiDownload the presentationLa PEC transfrontalière des PVVIH : recommandations
Author(s) : S. DialloDownload the presentationQuestions posées et enjeux de l'adoption d'une loi spécifique sur le VIH/sida : le cas du Niger
Author(s) : S. TchiombianoDownload the presentation
HIV/AIDS care and follow-up on a national scale in low resource settings: experience of the Niger Initiative on Antiretroviral Access (INAARV), NigerAuthor(s) : M. Ide, Y. Madec, M. Boubacar, E. Adehossi, C. Dezé, GM. Lawal, O. Amadou, S. Diallo, C. Pizzocolo, IA. Touré, S. Mamadou, C. Katlama and the National Technical Committee
Download the presentationPilot cell comprehensive care: a multidisciplinary service orientation and listening PHAs, NigerAuthor(s) : A. Alzouma, C. Dezé, B. Sabo, M. Bako, S. Maman, I. Mourtala, M. Goundara, F. Djermakoye, M. Ide, F. Aeberhard
Download the presentationThe impact of prior recourse to traditional medicine on the out-of-pocket expenditure of HIV/AIDS patients in NigerAuthor(s): S. Walker, S. Tchiombiano, A. Maiga, R. Hassane, M. Idé, AH. Souna, V. Bignon, O. Weil, L. Pizarro
Download the presentationIncidence and risk factor for tuberculosis (TB) in HIV patients on ART, Niger
Author(s): A. Foucher, Y. Madec, S. Diallo, Z. Thiousso, I. Dillé, S. Gambo, HA. Souna, A. Oumarou, A. Manou, GM. Laoual, Al. Touré, C. Pizzocolo, L. Pizarro, A. Fontanet
Download the presentationDecentralized access to triple therapy and viral load monitoring in West Africa (Mali)Author(s) : A. Akondé, Y. Madec, AB. Dicko, I. Haidarra, I. Katile, B. Diarra, M. Kye, A. Doumbia, C. Pizzocolo, C. Katlama and the Segou Medical Technical Committee
Download the presentationA method of HAART decentralization in rural areas: Solthis' experience in Segou (Mali)Author(s) : P. Teisseire, A. Akondé, C. Pizzocolo, S. Calmettes, S. Dalglish, N. Bodo, L. Pizarro
Download the presentationPrevention of mother-to-child transmission of HIV (PMTCT) in a rural setting : the experience of the Segou region in MaliAuthor(s) : CD. Traoré, A.akondé, T. Samake, T. Traoré, Y. Coulibaly, O. Coulibaly, A. Sidibé, D. Germanaud, Z. Traoré, A. Maiga, AG. Marcelin, C. Pizzocolo, C. Katlama and the Segou Medical Technical Committee
Download the presentationAppraisal of treatment modification in HIV patient follow-up in the region of Segou (Mali)Author(s) : J. Landier, A. Akondé, C. Pizzocolo, I. Haidara, M. Drabo, L. Pizarro, A. Fontanet, C. Katlama, Y. Madec
Download the presentationEtude virologique chez des sujets VIH-1 suivis à MadagascarAuthor(s) : F. Lamontagne, S. Andriantsimietry, ML. Chaix, JP. Viard, M. Randria, J. Nely, S. Randriamampionona, C. Aguilar, S. Royer, C. Pizzocolo, LR. Razanakolona, C. Rouzioux
Download the presentation
International AIDS Conference – Mexico City, August 2008
HIV-infected children in the context of the Niger Initiative on Antiretroviral Access (INAARV), Niger (West Africa)Author(s) : R. Abdoulaye-Mamadou, I. Adehossi, Y. Madec, C. Dezé, W. Alkassoum, M. Mahamane, I. Daouda, M. Amadou, D. Germanaud, C. Pizzocolo, S. Mamadou, C. Katlama and the National Technical Pediatric Committee
Download the presentationLooking for lost to follow-up patients: experiences of Segou (Mali)Author(s) : G. Lurton, A. Akondé, Y. Madec, P. Teisseire, T. Traore, B. Touré, D. Cissé, C. Koumaré, C. Pizzocolo, L. Pizarro, C. Katlama, and the Segou Medical Technical Committee
Download the presentation
L'observance au Niger : une approche socio-anthropologique utile à l'action
Author(s) : JP. Olivier de Sardan, A. Diarra, A. Moumouni
Download the presentationEvaluation des patients VIH/Sida ayant bénéficié d'un traitement ARV au sein de l'INAARV (Initiative Nigérienne d'Accès aux Antirétroviraux) : résultats à 2 ans
Author(s) : M. IdéDownload the presentationInfections opportunistes (IO) chez les patients infectés par le VIH traités par ARV au sein de l'INAARV (Initiative Nigérienne d'Accès aux Antirétroviraux)
Author(s) : B. MadougouDownload the presentationSolthis : une ONG médicale au service des pays du Sud
Author(s) : L. PizarroDownload the presentation
Evaluation d'un programme d'accès décentralisé aux antirétroviraux au Mali
Author(s) : AB. Dicko, MH. Maiga, A. Akondé, Y. Madec, C. Pizzocolo, le Comité thérapeutique de Ségou et le groupe de travail Solthis
Download the posterMise en place de la numération des lymphocytes T CD4+ par cytométrie de flux et suivi immunitaire des patients sous traitement antirétroviral à Ségou (Mali)
Author(s) : A. Maiga, B. Jarrousse, I. Haidara, L. Tegna, G. Carcelain, B. Autran, C. Katlama, le comité thérapeutique de Ségou et le groupe de travail Solthis
Download the posterEvaluation des enfants de moins de 5 ans nés de mères séropositives incluses dans l'INAARV
Author(s) : R. Abdoulaye-Mamadou, G.M. Lawal, A. Soumana, A. Gali-Yaroh, I. Adéossi, A. Harakoye, A. Diatta, M. Idé, Saïdou, C. Dézé, le comité médical technique du Niger et le groupe de travail Solthis
Download the poster
For active learning and fun of the management of HIV
Solthis offers a card game "The Therapeutic involved" in the form of a box intended for health professionals from developing countries to improve their knowledge of the management of HIV and its control in daily practice. Designed in 2008, this game has been used and tested regularly during the training provided by Solthis teams and their partners on the ground.
Sidaction to support for building Solthis pharmacists, helped edit a...
Le stockage ou l’accès technique est strictement nécessaire dans la finalité d’intérêt légitime de permettre l’utilisation d’un service spécifique explicitement demandé par l’abonné ou l’utilisateur, ou dans le seul but d’effectuer la transmission d’une communication sur un réseau de communications électroniques.
Le stockage ou l’accès technique est nécessaire dans la finalité d’intérêt légitime de stocker des préférences qui ne sont pas demandées par l’abonné ou l’utilisateur.
Le stockage ou l’accès technique qui est utilisé exclusivement à des fins statistiques.Le stockage ou l’accès technique qui est utilisé exclusivement dans des finalités statistiques anonymes. En l’absence d’une assignation à comparaître, d’une conformité volontaire de la part de votre fournisseur d’accès à internet ou d’enregistrements supplémentaires provenant d’une tierce partie, les informations stockées ou extraites à cette seule fin ne peuvent généralement pas être utilisées pour vous identifier.
Le stockage ou l’accès technique est nécessaire pour créer des profils d’utilisateurs afin d’envoyer des publicités, ou pour suivre l’utilisateur sur un site web ou sur plusieurs sites web à des fins de marketing similaires.